Stock Price
4.07
Daily Change
-1.06 -20.66%
Monthly
3.56%
Yearly
126.11%
Q2 Forecast
5.00

Acasti Pharma reported $-2.53M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acasti Pharma USD -2.53M 560K Sep/2025
Addus HomeCare USD 42.28M 9.34M Dec/2025
Amarin USD -2.26M 564K Dec/2025
Cassava Sciences USD -13.55M 1.69M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Option Care Health USD 91.5M 6.99M Dec/2025
Organigram Holdings CAD -20.13M 7.92M Dec/2025
Tilray USD -20.01M 9.34M Sep/2025